CFS Clinical Chooses C3i Tech Support
CFS Clinical has selected C3i, a service desk support and business process outsourcing services provider.
CFS Clinical has selected C3i, a service desk support and business process outsourcing services provider. C3i is providing global 24x365 multilingual technology support services for CFS’ Site Activation and Investigator Payment Services. The service desk supports active clinical trial sites in nearly 50 countries and 12 languages, staffed out of C3i’s Sofia Operations Center. Additional languages will be added later this year, to manage CFS’ continued scaling, supported out of C3i’s Dalian Operations Center.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
